October 4, 2024
The Center will enable targeted and untargeted metabolic profiling for population-based large-scale cohorts across translational research SINGAPORE, Singapore -- Agilent Technologies Inc. (NYSE: A) today announced a new strategic partnership with the National University of Singapore (NUS), acting through the Yong Loo Lin School of Medicine (NUS Medicine), to establish the NUS-Agilent Center of Excellence (CoE) in [...]
October 3, 2024
SALT LAKE CITY and FREMONT, Calif. -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput next-generation sequencing (NGS) platform, today announced a joint effort to explore Ultima’s UG 100™ sequencing platform and its ppmSeq™ technology to advance Myriad’s ability to [...]
October 3, 2024
The collaboration leverages Nyctea's unique expertise and its proprietary Nyctea® platform technology to improve the purification process for a drug compound that AstraZeneca is developing within its Research and Development program. Under the collaboration, Nyctea Technologies will apply its proprietary Nyctea® platform for improving purification of advanced therapy medicinal products (ATMPs). The Nyctea® platform stands [...]
H.E.L Group introduces iso-BTC e to advance semiconductor technologies
October 3, 2024
New specialized isothermal calorimeter enables direct measurement of heat dissipation and optimization of thermal management and design London, UK: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the introduction of the iso-BTC e, a benchtop isothermal calorimeter for the precise measurement of heat dissipation [...]
Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors
October 3, 2024
MARLBOROUGH, Mass. -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), the Spatial Biology Company®, today announced Scott Mendel has been appointed as Chairman of its Board, effective October 2, 2024. Mr. Mendel succeeds Robert Shepler, founding Chairman, who will remain on Akoya’s board. Mr. Mendel has served as a member of Akoya’s board of directors since [...]
Charles Dadswell to step down as General Counsel, Illumina initiates search for successor
October 3, 2024
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that after 11 years of service, Charles "Chuck" Dadswell will step down as General Counsel and Secretary on October 3. Dadswell has agreed to remain an Illumina employee, serving as an advisor to CEO Jacob Thaysen and the Board [...]
Genomenon Targets WGS Analysis Costs with Curated ACMG Secondary Findings
October 3, 2024
Curated Variants for ACMG Secondary Findings Genes now in Mastermind Ann Arbor, MI – Genomenon, Inc., a leading genomic intelligence company, announced the curation of evidence for the American College of Medical Genetics and Genomics (ACMG) secondary findings genes within its Mastermind software platform. This significant enhancement enables laboratories to rapidly interpret medically valuable genetic [...]
eLabNext Launches New Brand Positioning with Centralized Digital Lab Platform
October 3, 2024
eLabNext unveils a unified Digital Lab Platform (DLP), merging ELN, LIMS, and lab management solutions to streamline research, enhance collaboration, and meet modern lab needs. eLabNext, Your Go-to Digital Lab Platform for Streamlined Research Groningen, NL — eLabNext, a leading provider of digital lab management solutions, is proud to announce a significant shift in its [...]
Xenocs and Malvern Panalytical collaborate to advance pharmaceutical analytics
October 3, 2024
Grenoble -- Xenocs, a global leader in Small Angle X-ray Scattering (SAXS) technology, and Malvern Panalytical, renowned for its expertise in materials characterization, are pleased to announce a collaboration aimed at transforming pharmaceutical analytics. This joint marketing initiative will deliver a unique, comprehensive solution to the pharmaceutical sector’s analytical challenges. Through various initiatives, such as [...]
October 2, 2024
New York, NY and Strasbourg, France – Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announced today that it has expanded internationally via a partnership with FAMECO Group ApS (“FAMECO” or the “Company”). Terms of the transaction were not disclosed. Founded in 2000 and headquartered in Strasbourg, France, FAMECO is an international [...]

